Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study.
Saved in:
| Title: | Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study. |
|---|---|
| Authors: | Bruel T; Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France.; Vaccine Research Institute, Créteil, France., Pinaud L; Emerging Diseases Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, France., Tondeur L; Emerging Diseases Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, France., Planas D; Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France.; Vaccine Research Institute, Créteil, France., Staropoli I; Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France., Porrot F; Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France., Guivel-Benhassine F; Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France., Attia M; Molecular Genetics of RNA Viruses Unit, Institut Pasteur, Université Paris Cité, Paris, France., Pelleau S; Infectious Disease Epidemiology and Analytics Unit, Institut Pasteur, Université Paris Cité, Paris, France., Woudenberg T; Infectious Disease Epidemiology and Analytics Unit, Institut Pasteur, Université Paris Cité, Paris, France., Duru C; Hôpital de Crépy-en-Valois, Crépy-en-Valois, France., Koffi AD; Hôpital de Crépy-en-Valois, Crépy-en-Valois, France., Castelain S; Laboratoire de virologie, CHU Amiens, AGIR UR4294, UPJV, Amiens, France., Fernandes-Pellerin S; Centre for Translational Science, Institut Pasteur, Paris, France., Jolly N; Centre for Translational Science, Institut Pasteur, Paris, France., De Facci LP; Clinical Investigation and access to bioresources (ICAReB) platform, Centre for Translational Science, Institut Pasteur, Paris, France., Roux E; Clinical Investigation and access to bioresources (ICAReB) platform, Centre for Translational Science, Institut Pasteur, Paris, France., Ungeheuer MN; Clinical Investigation and access to bioresources (ICAReB) platform, Centre for Translational Science, Institut Pasteur, Paris, France., Van Der Werf S; Molecular Genetics of RNA Viruses Unit, Institut Pasteur, Université Paris Cité, Paris, France., White M; Infectious Disease Epidemiology and Analytics Unit, Institut Pasteur, Université Paris Cité, Paris, France., Schwartz O; Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France.; Vaccine Research Institute, Créteil, France., Fontanet A; Emerging Diseases Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, France.; Conservatoire National des Arts et Métiers, PACRI Unit, Paris, France. |
| Source: | EClinicalMedicine [EClinicalMedicine] 2022 Jul 22; Vol. 51, pp. 101576. Date of Electronic Publication: 2022 Jul 22 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35891947 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bruel+T%22">Bruel T</searchLink>; Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France.; Vaccine Research Institute, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Pinaud+L%22">Pinaud L</searchLink>; Emerging Diseases Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Tondeur+L%22">Tondeur L</searchLink>; Emerging Diseases Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Planas+D%22">Planas D</searchLink>; Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France.; Vaccine Research Institute, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Staropoli+I%22">Staropoli I</searchLink>; Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France.<br /><searchLink fieldCode="AU" term="%22Porrot+F%22">Porrot F</searchLink>; Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France.<br /><searchLink fieldCode="AU" term="%22Guivel-Benhassine+F%22">Guivel-Benhassine F</searchLink>; Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France.<br /><searchLink fieldCode="AU" term="%22Attia+M%22">Attia M</searchLink>; Molecular Genetics of RNA Viruses Unit, Institut Pasteur, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Pelleau+S%22">Pelleau S</searchLink>; Infectious Disease Epidemiology and Analytics Unit, Institut Pasteur, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Woudenberg+T%22">Woudenberg T</searchLink>; Infectious Disease Epidemiology and Analytics Unit, Institut Pasteur, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Duru+C%22">Duru C</searchLink>; Hôpital de Crépy-en-Valois, Crépy-en-Valois, France.<br /><searchLink fieldCode="AU" term="%22Koffi+AD%22">Koffi AD</searchLink>; Hôpital de Crépy-en-Valois, Crépy-en-Valois, France.<br /><searchLink fieldCode="AU" term="%22Castelain+S%22">Castelain S</searchLink>; Laboratoire de virologie, CHU Amiens, AGIR UR4294, UPJV, Amiens, France.<br /><searchLink fieldCode="AU" term="%22Fernandes-Pellerin+S%22">Fernandes-Pellerin S</searchLink>; Centre for Translational Science, Institut Pasteur, Paris, France.<br /><searchLink fieldCode="AU" term="%22Jolly+N%22">Jolly N</searchLink>; Centre for Translational Science, Institut Pasteur, Paris, France.<br /><searchLink fieldCode="AU" term="%22De+Facci+LP%22">De Facci LP</searchLink>; Clinical Investigation and access to bioresources (ICAReB) platform, Centre for Translational Science, Institut Pasteur, Paris, France.<br /><searchLink fieldCode="AU" term="%22Roux+E%22">Roux E</searchLink>; Clinical Investigation and access to bioresources (ICAReB) platform, Centre for Translational Science, Institut Pasteur, Paris, France.<br /><searchLink fieldCode="AU" term="%22Ungeheuer+MN%22">Ungeheuer MN</searchLink>; Clinical Investigation and access to bioresources (ICAReB) platform, Centre for Translational Science, Institut Pasteur, Paris, France.<br /><searchLink fieldCode="AU" term="%22Van+Der+Werf+S%22">Van Der Werf S</searchLink>; Molecular Genetics of RNA Viruses Unit, Institut Pasteur, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22White+M%22">White M</searchLink>; Infectious Disease Epidemiology and Analytics Unit, Institut Pasteur, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Schwartz+O%22">Schwartz O</searchLink>; Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Paris, France.; Vaccine Research Institute, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Fontanet+A%22">Fontanet A</searchLink>; Emerging Diseases Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, France.; Conservatoire National des Arts et Métiers, PACRI Unit, Paris, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101733727%22">EClinicalMedicine</searchLink> [EClinicalMedicine] 2022 Jul 22; Vol. 51, pp. 101576. <i>Date of Electronic Publication: </i>2022 Jul 22 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22The+Lancet%22">The Lancet </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101733727 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2589-5370 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225895370%22">25895370 </searchLink><i>NLM ISO Abbreviation: </i>EClinicalMedicine <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35891947 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.eclinm.2022.101576 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 101576 Titles: – TitleFull: Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bruel T – PersonEntity: Name: NameFull: Pinaud L – PersonEntity: Name: NameFull: Tondeur L – PersonEntity: Name: NameFull: Planas D – PersonEntity: Name: NameFull: Staropoli I – PersonEntity: Name: NameFull: Porrot F – PersonEntity: Name: NameFull: Guivel-Benhassine F – PersonEntity: Name: NameFull: Attia M – PersonEntity: Name: NameFull: Pelleau S – PersonEntity: Name: NameFull: Woudenberg T – PersonEntity: Name: NameFull: Duru C – PersonEntity: Name: NameFull: Koffi AD – PersonEntity: Name: NameFull: Castelain S – PersonEntity: Name: NameFull: Fernandes-Pellerin S – PersonEntity: Name: NameFull: Jolly N – PersonEntity: Name: NameFull: De Facci LP – PersonEntity: Name: NameFull: Roux E – PersonEntity: Name: NameFull: Ungeheuer MN – PersonEntity: Name: NameFull: Van Der Werf S – PersonEntity: Name: NameFull: White M – PersonEntity: Name: NameFull: Schwartz O – PersonEntity: Name: NameFull: Fontanet A IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 07 Text: 2022 Jul 22 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2589-5370 Numbering: – Type: volume Value: 51 Titles: – TitleFull: EClinicalMedicine Type: main |
| ResultId | 1 |